Drug intelligence / Profile preview

technetium Tc 99m tilmanocept + vital blue dye

Development stage
Unknown
Lead developer
Navidea Biopharmaceuticals
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intradermal, Subcutaneous, Peritumoral, Submucosal
01

Overview

Technetium Tc 99m tilmanocept (Lymphoseek) combined with a vital blue dye (such as isosulfan blue or Patent Blue V) is used for lymphatic mapping and sentinel lymph node biopsy in patients with solid tumors. Lymphoseek is a radioactive diagnostic agent that binds to the CD206 mannose receptor on macrophages and dendritic cells within lymph nodes. The radiolabeled agent allows for intraoperative detection of sentinel lymph nodes using a handheld gamma counter. Vital blue dyes are visual tracers that stain the lymphatic vessels and nodes to aid in their identification during surgery. This combination improves the accuracy of identifying sentinel lymph nodes compared to either agent alone[5][7][8]. Lymphoseek was developed by Navidea and has demonstrated superior performance over vital blue dyes alone in clinical trials for breast cancer and melanoma[6][8].

Brand names
LymphazurinPatent Blue V
Other names
tilmanocept[99mTc]tilmanocept
02

Targets

MRC1 (Mannose Receptor C-type 1)

Beyond the preview

Go deeper on technetium Tc 99m tilmanocept + vital blue dye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m tilmanocept + vital blue dye.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call